Metformin

immunoglobulin heavy diversity 1-14 (non-functional) ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29456855 Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. 2018 Mar 3
2 30684325 Chronic systemic inflammation in the pathogenesis of comorbid pathology and it's correction. 2018 1
3 30918874 The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen. 2018 Dec 1
4 28985579 Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale. 2017 Nov 1
5 29047344 Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing. 2017 Oct 16 5
6 27079349 Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus. 2016 Apr 2
7 25468944 The effect of metformin on glucose homeostasis during moderate exercise. 2015 Feb 2
8 25683794 Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta-analysis. 2015 Mar 1
9 23808738 [Metabolic syndrome and prediabetic states]. 2013 Jun 1
10 23983487 Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. 2013 3
11 24082827 Prevention of diabetes in family medicine. 2013 1
12 24308813 Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer? 2013 Dec 5 1
13 21298495 Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin. 2012 Jun 3
14 20331505 Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. 2010 May 1
15 20572306 Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. 2010 Jun 28 2
16 18401838 Prevalence of risk determinants for metformin-associated lactic acidosis and metformin utilization in the study of health in pomerania. 2008 Jul 2
17 18837086 Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. 2008 Oct 7 1
18 18038714 Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. 2007 Sep 2
19 18062354 [Therapeutic options for metabolic syndrome in obese patients]. 2007 Sep-Oct 1
20 18399062 Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. 2007 1
21 31627625 [Postprandial glyсеmia, body weight, and cardiovascular parameters in diabetes type 2 in metformin monotherapy]. 2007 Feb 15 2
22 16503324 Possible metformin-induced hepatotoxicity. 2005 Dec 5
23 15506677 Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus. 2004 Sep 1
24 12769787 Metformin and its liver targets in the treatment of type 2 diabetes. 2003 Jun 3